← Product Code [MUI](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MUI) · K072515

# EMBRACE GEL (K072515)

_Orison Corporation · MUI · Sep 20, 2007 · Radiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MUI/K072515

## Device Facts

- **Applicant:** Orison Corporation
- **Product Code:** [MUI](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MUI.md)
- **Decision Date:** Sep 20, 2007
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 892.1570
- **Device Class:** Class 2
- **Review Panel:** Radiology
- **Attributes:** 3rd-Party Reviewed

## Intended Use

Embrace Gel is intended for use as an ultrasound coupling media for use with the Embrace™ 3D Ultrasound Tomography System K070477.

## Device Story

Embrace Gel is an expandable polymer pad used as an ultrasound coupling medium. It is placed in the dome of the Embrace™ 3D Ultrasound Tomography System and hydrated prior to scanning. The pad expands to fill voids between the breast tissue and the ultrasound probe, ensuring acoustic coupling. After the scan, the gel is removed in one piece. It is used in a clinical setting by trained operators of the Embrace™ system to facilitate high-quality ultrasound imaging of breast tissue.

## Clinical Evidence

No clinical data provided; bench testing only.

## Technological Characteristics

Expandable polymer gel pad; functions as an acoustic coupling medium for ultrasound imaging. Dimensions and material specifications are not detailed.

## Regulatory Identification

A diagnostic ultrasonic transducer is a device made of a piezoelectric material that converts electrical signals into acoustic signals and acoustic signals into electrical signals and intended for use in diagnostic ultrasonic medical devices. Accessories of this generic type of device may include transmission media for acoustically coupling the transducer to the body surface, such as acoustic gel, paste, or a flexible fluid container.

## Predicate Devices

- Aquasonic 100 Ultrasound Trans Gel ([K802146](/device/K802146.md))

## Reference Devices

- Embrace™ 3D Ultrasound Tomography System ([K070477](/device/K070477.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

K072515

## 510(K) SUMMARY (as required by 807.92(c))

SEP 2 0 2007

| Submitter of 510(k):    | Orison Corporation<br>121 Boone Ridge Dr, Suite 2004<br>Johnson City, TN 37615<br>USA |
|-------------------------|---------------------------------------------------------------------------------------|
|                         | Phone: (423) 282-5919<br>Fax: (423) 282-6320                                          |
| Contact Person:         | Al Sandy                                                                              |
| Date of Summary:        | April 4, 2007                                                                         |
| Trade/Proprietary Name: | Embrace Gel                                                                           |
| Classification Name:    | Diagnostic, Ultrasonic, Transducer                                                    |
| Product Code:           | MUI                                                                                   |

#### Intended Use:

Embrace Gel is intended for use as an ultrasound coupling media for use with the Embrace™ 3D Ultrasound Tomography System K070477.

#### Device Description:

Embrace™ Gel Pad is en expandable polymer used to provide a coupling medium between breast tissue and the Embrace™ 3D Ultrasound Tomography System K070477. The gel is prepared just prior to scanning by placing the gel pad in the dome and adding hydrating fluid. The gel pad expands and fills the voids between the probe and breast tissue. After the ultrasound scan is completed, the gel is removed from the dome in one piece.

#### Predicate Device:

Aquasonic 100 Ultrasound Trans Gel K802146

#### Substantial Equivalence:

The Embrace Gel provides an effective coupling between the tissue being examined and the ultrasound unit. Its function and performance are similar to the predicate device as presented in this 510(k)

{1}------------------------------------------------

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows a circular logo with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" written around the perimeter of the circle. Inside the circle is a stylized image of an eagle. The eagle is drawn with three curved lines that form the body, wing, and head.

Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850

### SEP 2 0 2007

Orison Corporation % Mr. Daniel W. Lehtonen Responsible Third Party Official Intertek Testing Services NA, Inc. 2307 E. Aurora Rd., Unit B7 TWINSBURG OH 44087

Re: K072515

Trade/Device Name: Embrace Gel Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: MUI Dated: September 6, 2007 Received: September 7, 2007

#### Dear Mr. Lehtonen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for. use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your. device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Image /page/1/Picture/10 description: The image shows a circular logo with the text "1906-2006" at the top. Below the text is a large, stylized "FDA" in bold letters. Underneath the letters, the word "Centennial" is written in a cursive font. At the bottom of the logo, there are three stars arranged horizontally. 

Prosoting and Promoting Publio Statte

{2}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin markeung your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|----------------|----------------------------------|--------------|
| 21 CFR 884.xxx | (Obstetrics/Gynecology)          | 240-276-0115 |
| 21 CFR 894.xxx | (Radiology)                      | 240-276-0120 |
| Other          |                                  | 240-276-0100 |

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150

or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.

Sincerely yours.

Nancy C. Hogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

# Indications for Use

072515 510(k) Number (if known):

Device Name: Embrace Gel

Indications for Use:

Embrace Gel is intended for use as an ultrasound coupling media for use with the Embrace™ 3D Ultrasound Tomography System (K070477)

Prescription Use Yes (Part 21 CFR 801 Subpart D)

Over-The-Counter Use N/A AND/OR (21 CFR 801 Subpart C)

e-Counter Use N/A
CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number K072515

7 of 47

---

**Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MUI/K072515](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MUI/K072515)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com